Trials / Completed
CompletedNCT05528653
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Vivent Health · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)
Detailed description
The goal of this study is to determine whether incorporating a telehealth model that allows for same-day appointments for PrEP delivery with the support of navigation leads to increased uptake and persistence of PrEP in young MSM/transgender of color and individuals in rural communities that have disproportionately not used PrEP. The investigators will accomplish this by using an effectiveness-hybrid design that will allow us to both evaluate the interventions impact on relevant clinical outcomes as well as the effectiveness of the implementation strategy. Our hypothesis is that by removing some of the barriers to care such as transportation, childcare, work schedule and potentially stigma with repeated clinic visits, the investigators will increase the uptake and persistence of PrEP amongst communities who historically have had many barriers to care and have not started PrEP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Descovy | HIV infection pre-exposure prophylaxis |
Timeline
- Start date
- 2022-07-19
- Primary completion
- 2024-07-31
- Completion
- 2025-03-21
- First posted
- 2022-09-06
- Last updated
- 2025-09-23
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05528653. Inclusion in this directory is not an endorsement.